Safety & Performance Study of Lumen Biomedical's FiberNet Distal Protection System for the Treatment of Renal Artery Stenosis

NAUnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

June 30, 2009

Conditions
Renal Stenting in the Treatment of Pts w/a High Grade Ostial Atherosclerotic Renal Lesion(s).
Interventions
DEVICE

Lumen Biomedical FiberNet Embolic Protection System

to demonstrate the safety and filter efficiency of the Lumen Biomedical FiberNet Embolic Protection System during the performance of primary renal stenting in the treatment of pts with a high grade ostial atherosclerotic renal lesion(s).

Trial Locations (1)

95123

VIVA Physicians Inc., San Jose

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Lumen Biomedical

INDUSTRY

collaborator

Prairie Education and Research Cooperative

INDUSTRY

lead

VIVA Physicians

OTHER